Access our on-demand webinar.
Lipid nanoparticles (LNPs) have emerged as popular vehicles for delivering various types of drugs such as mRNA and gene therapy. While these nanoparticles are effective in transporting therapeutic payloads, their components can interact with the human body, potentially causing genotoxicity — damage to the recipient’s genetic material that may lead to inheritable mutations or cancer.
In this webinar, Dr. Shambhu Roy will discuss how to test the genotoxicity of LNP-based therapeutics to ensure the safety of these innovative drug delivery systems.
Our expert discusses:
- Understanding the key components of LNP delivery systems
- Genotoxicity testing for LNP-based drugs during preclinical safety assessment
- Selecting the appropriate assays to meet regulatory requirements
Don't miss this opportunity to gain valuable insights and stay ahead in drug development.
Complete the form to access this on-demand webinar.
